Thu
16 Jan
2020

AgilVax Announces Expansion of Series A-1 Financing

Read More

Mon
18 Nov
2019

AgilVax to Present Positive Preclinical Data for Monoclonal Antibody Targeting xCT at the American Association for Cancer Research’s Tumor Immunology and Immunotherapy Conference

Read More

Thu
07 Nov
2019

AgilVax to Present at the 2019 NYC Oncology Investor Conference

Read More

Thu
25 Jul
2019

AgilVax Appoints Dr. Joseph Patti as Chief Executive Officer

Read More

Wed
29 May
2019

AgilVax Triggers $2 Million Phase II Fast Track SBIR Grant and Initiates GMP Manufacturing

Read More

Wed
09 Jan
2019

AgilVax Elects Dr. David T. Hung, Former Founder and CEO of Medivation, to Its Board of Directors

Read More

Tue
13 Nov
2018

AgilVax Appoints Joseph Patti, Ph.D. as Executive Chairman

Read More

Tue
07 Aug
2018

AgilVax Awarded $2.3 Million SBIR Fast Track Grant to Advance the Development of AX09 for Triple Negative Breast Cancer

Read More

Tue
15 May
2018

AgilVax Closes A1 Financing to Expand Pre-IND Studies for AX09 In Triple Negative Breast Cancer

Read More

Tue
01 May
2018

AgilVax Establishes Operations at JLABS @ TMC in Houston

Read More

Thu
04 Jan
2018

AgilVax to Attend J.P. Morgan Healthcare Conference, Biotech Showcase™ 2018 & RESI San Francisco 2018

Read More

Tue
05 Dec
2017

New Scientific Publication Supports AgilVax’s Novel Immunotherapy Development for Metastatic Breast Cancer

Read More

Thu
06 Apr
2017

AgilVax Selected for Springboard Health Innovation Hub 2017

Read More

Fri
31 Mar
2017

AgilVax to Showcase Data During AACR 2017 Annual Meeting in Washington, DC

Read More